Niaspan treatment increases tumor necrosis factor-α-converting enzyme and promotes arteriogenesis after stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 29, Issue 5, 2009, Pages 911-920

  Chen, Jieli ^a   Cui, Xu ^a   Zacharek, Alex ^a   Ding, Guang Liang ^a   Shehadah, Amjad ^a   Jiang, Quan ^a   Lu, Mei ^b   Chopp, Michael ^a,c  

^a HENRY FORD HOSPITAL   (United States)

^b HENRY FORD HEALTH SCIENCES CENTER   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

Arteriogenesis; CBF; Niaspan; Stroke; TACE

Indexed keywords

NICOTINIC ACID; NOTCH1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR; ADAM PROTEIN; NOTCH1 PROTEIN, RAT; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BRAIN BLOOD FLOW; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; GENE EXPRESSION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; UPREGULATION; ANIMAL; BIOSYNTHESIS; BRAIN; BRAIN CIRCULATION; CELL CULTURE; CEREBRAL ARTERY DISEASE; DELAYED RELEASE FORMULATION; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; METABOLISM; MICROCIRCULATION; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION; WISTAR RAT;

ADAM PROTEINS; ANIMALS; BRAIN; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; NIACIN; RATS; RATS, WISTAR; RECEPTOR, NOTCH1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 65549168338     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/jcbfm.2009.11     Document Type: Article

References (41)

1. Buschmann IR, Busch HJ, Mies G, Hossmann KA (2003) Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colonystimulating factor. Circulation 108:610-5
2. Chen J, Cui X, Zacharek A, Chopp M (2008) Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke. J Cell Mol Med (in Press)
3. Chen J, Cui X, Zacharek A, Jiang H, Roberts C, Zhang C, Lu M, Kapke A, Feldkamp CS, Chopp M (2007) Niaspan increases angiogenesis and improves functional recovery after stroke. Ann Neurol 62:49-58
4. Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32:2682-8
5. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53:743-51
6. Chopp M, Zhang ZG, Jiang Q (2007) Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke 38:827-31
7. Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP (2005) Angiographic assessment of pial collaterals as a prognostic indicator following intraarterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 26:1789-97
8. Deindl E, Schaper W (2005) The art of arteriogenesis. Cell Biochem Biophys 43:1-15
9. Edwards DR, Handsley MM, Pennington CJ (2008) The ADAM metalloproteinases. Mol Aspects Med 29:258-89
10. Ehebauer M, Hayward P, Arias AM (2006) Notch, a universal arbiter of cell fate decisions. Science 314:1414-5
11. Fischer A, Schumacher N, Maier M, Sendtner M, Gessler M (2004) The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev 18:901-11
12. Garton KJ, Gough PJ, Philalay J, Wille PT, Blobel CP, Whitehead RH, Dempsey PJ, Raines EW(2003) Stimulated shedding of vascular cell adhesion molecule 1 (VCAM-1) is mediated by tumor necrosis factor-alpha-converting enzyme (ADAM 17). J Biol Chem 278:37459-64
13. Gridley T (2007) Notch signaling in vascular development and physiology. Development 134:2709-18
14. Grundmann S, Hoefer I, Ulusans S, van Royen N, Schirmer SH, Ozaki CK, Bode C, Piek JJ, Buschmann I (2005) Antitumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbit. Am J Physiol Heart Circ Physiol 289:H1497-505
15. Heil M, Eitenmuller I, Schmitz-Rixen T, Schaper W (2006) Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10:45-55
16. Heil M, Schaper W (2004) Influence of mechanical, cellular, and molecular factors on collateral artery growth (arteriogenesis). Circ Res 95:449-58
17. Heil M, Schaper W (2005) Arteriogenic growth factors, chemokines and proteases as a prerequisite for arteriogenesis. Drug News Perspect 18:317-22
18. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, Cook JJ (2001) Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 49:618-25
19. Ho TK, Rajkumar V, Black CM, Abraham DJ, Baker DM (2006) Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia. Br J Surg 93:1368-76
20. Hoefer IE, van Royen N, Rectenwald JE, Bray EJ, Abouhamze Z, Moldawer LL, Voskuil M, Piek JJ, Buschmann IR, Ozaki CK (2002) Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis. Circulation 105:1639-41
21. Hoefer IE, van Royen N, Rectenwald JE, Deindl E, Hua J, Jost M, Grundmann S, Voskuil M, Ozaki CK, Piek JJ, Buschmann IR (2004) Arteriogenesis proceeds via ICAM-1/Mac-1-mediated mechanisms. Circ Res 94:1179-85
22. Jarriault S, Brou C, Logeat F, Schroeter EH, Kopan R, Israel A (1995) Signalling downstream of activated mammalian Notch. Nature 377:355-8
23. Katakowski M, Chen J, Zhang ZG, Santra M, Wang Y, Chopp M (2007) Stroke-induced subventricular zone proliferation is promoted by tumor necrosis factoralpha-converting enzyme protease activity. J Cereb Blood Flow Metab 27:669-78
24. Lawson ND, Vogel AM, Weinstein BM (2002) Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 3:127-36
25. Liebeskind DS (2004) Collateral therapeutics for cerebral ischemia. Expert Rev Neurother 4:255-65
26. Liebeskind DS (2005) Neuroprotection from the collateral perspective. IDrugs 8:222-8
27. Limbourg A, Ploom M, Elligsen D, Sorensen I, Ziegelhoeffer T, Gossler A, Drexler H, Limbourg FP (2007) Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ Res 100:363-71
28. Liu ZJ, Shirakawa T, Li Y, Soma A, Oka M, Dotto GP, Fairman RM, Velazquez OC, HerlynM(2003) Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 23:14-25
29. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R (2000) A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5:197-206
30. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, Windecker S, Eberli FR, Meier B (2001) Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 38:1872-8
31. Proweller A,Wright AC, Horng D, Cheng L, Lu MM, Lepore JJ, Pear WS, Parmacek MS (2007) Notch signaling in vascular smooth muscle cells is required to pattern the cerebral vasculature. Proc Natl Acad Sci USA 104:16275-80
32. Ridgway J, Zhang G, Wu Y, Stawicki S, Liang WC, Chanthery Y, Kowalski J, Watts RJ, Callahan C, Kasman I, Singh M, Chien M, Tan C, Hongo JA, de Sauvage F, Plowman G, Yan M (2006) Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 444:1083-7
33. Roca C, Adams RH (2007) Regulation of vascular morphogenesis by Notch signaling. Genes Dev 21:2511-24
34. Saward L, Zahradka P (1997) Coronary artery smooth muscle in culture: migration of heterogeneous cell populations from vessel wall. Mol Cell Biochem 176:53-9
35. Scholz D, Ito W, Fleming I, Deindl E, Sauer A, Wiesnet M, Busse R, Schaper J, SchaperW(2000) Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch 436:257-70
36. Thored P, Wood J, Arvidsson A, Cammenga J, Kokaia Z, Lindvall O (2007) Long-term neuroblast migration along blood vessels in an area with transient angiogenesis and increased vascularization after stroke. Stroke 38:3032-9
37. Todo K, Kitagawa K, Sasaki T, Omura-Matsuoka E, Terasaki Y, Oyama N, Yagita Y, Hori M (2008) Granulocytemacrophage colony-stimulating factor enhances leptomeningeal collateral growth induced by common carotid artery occlusion. Stroke 39:1875-82
38. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W (2001) Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49:543-53
39. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G (2001) Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 108:161-4
40. Vooijs M, Ong CT, Hadland B, Huppert S, Liu Z, Korving J, van den Born M, Stappenbeck T, Wu Y, Clevers H, Kopan R (2007) Mapping the consequence of Notch1 proteolysis in vivo with NIP-CRE. Development 134:535-44
41. Williams DS, Detre JA, Leigh JS, Koretsky AP (1992) Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 89:212-6